Travilah Consulting Group
Palo Alto, Californiatcg-x.com
Overview
TCG Crossover, known as TCGX, is a healthcare and life sciences-focused investment firm that invests in both private and public companies. The firm focuses on innovative drug discovery companies and leverages a network of scientific advisors and operational executives to support its portfolio. TCGX employs a long-term, patient capital strategy through a closed-end fund structure. The firm was founded in 2021 by Dr. Chen Yu and has offices in Palo Alto and New York City.
Portfolio Companies
4
Website
tcg-x.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mineralys Therapeutics | Feb 2024 | Private Placement | Co-investor |
| Cargo Therapeutics | Mar 2023 | Series A | - |
| RayzeBio | Jun 2021 | Series C | - |
| LianBio | Oct 2020 | Series A | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
